Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: Antigenicity, biophysics, and immunogenicity

Barna Dey, Marie Pancera, Krisha Svehla, Yuuei Shu, Shi Hua Xiang, Jeffrey Vainshtein, Yuxing Li, Joseph Sodroski, Peter D. Kwong, John R. Mascola, Richard Wyatt

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

The human immunodeficiency virus type 1 exterior gp120 envelope glycoprotein is highly flexible, and this flexibility may contribute to the inability of monomelic gp 120 immunogens to elicit broadly neutralizing antibodies. We previously showed that an S375W modification of a critical interfacial cavity central to the primary receptor binding site, the Phe43 cavity, stabilizes gp120 into the CD4-bound state. However, the immunological effects of this cavity-altering replacement were never tested. Subsequently, we screened other mutations that, along with the S375W alteration, might further stabilize the CD4-bound state. Here, we define a selected second cavity-altering replacement, T257S, and analyze the double mutations in several gp120 envelope glycoprotein contexts. The gp120 glycoproteins with the T257S-plus-S375W double mutation (T257S+S375W) have a superior antigenic profile compared to the originally identified single S375W replacement in terms of enhanced recognition by the broadly neutralizing CD4 binding-site antibody b12. Isothermal titration calorimetry measuring the entropy of the gp120 interaction with CD4 indicated that the double mutant was also stabilized into the CD4-bound state, with increasing relative fixation between core, full-length monomelic, and full-length trimeric versions of gp120. A significant increase in gp120 affinity for CD4 was also observed for the cavity-filling mutants relative to wild-type gp120. The most conformationally constrained T257S+S375W trimeric gp120 proteins were selected for immunogenicity analysis in rabbits and displayed a trend of improvement relative to their wild-type counterparts in terms of eliciting neutralizing antibodies. Together, the results suggest that conformational stabilization may improve the ability of gp120 to elicit neutralizing antibodies.

Original languageEnglish (US)
Pages (from-to)5579-5593
Number of pages15
JournalJournal of virology
Volume81
Issue number11
DOIs
StatePublished - Jun 1 2007

Fingerprint

Biophysics
biophysics
Human immunodeficiency virus 1
Neutralizing Antibodies
neutralizing antibodies
HIV-1
glycoproteins
Glycoproteins
immune response
mutation
Mutation
Antibody Binding Sites
mutants
Calorimetry
calorimetry
Entropy
entropy
titration
neutralization
binding sites

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state : Antigenicity, biophysics, and immunogenicity. / Dey, Barna; Pancera, Marie; Svehla, Krisha; Shu, Yuuei; Xiang, Shi Hua; Vainshtein, Jeffrey; Li, Yuxing; Sodroski, Joseph; Kwong, Peter D.; Mascola, John R.; Wyatt, Richard.

In: Journal of virology, Vol. 81, No. 11, 01.06.2007, p. 5579-5593.

Research output: Contribution to journalArticle

Dey, Barna ; Pancera, Marie ; Svehla, Krisha ; Shu, Yuuei ; Xiang, Shi Hua ; Vainshtein, Jeffrey ; Li, Yuxing ; Sodroski, Joseph ; Kwong, Peter D. ; Mascola, John R. ; Wyatt, Richard. / Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state : Antigenicity, biophysics, and immunogenicity. In: Journal of virology. 2007 ; Vol. 81, No. 11. pp. 5579-5593.
@article{65ee770055344836a55045a55c007a5a,
title = "Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: Antigenicity, biophysics, and immunogenicity",
abstract = "The human immunodeficiency virus type 1 exterior gp120 envelope glycoprotein is highly flexible, and this flexibility may contribute to the inability of monomelic gp 120 immunogens to elicit broadly neutralizing antibodies. We previously showed that an S375W modification of a critical interfacial cavity central to the primary receptor binding site, the Phe43 cavity, stabilizes gp120 into the CD4-bound state. However, the immunological effects of this cavity-altering replacement were never tested. Subsequently, we screened other mutations that, along with the S375W alteration, might further stabilize the CD4-bound state. Here, we define a selected second cavity-altering replacement, T257S, and analyze the double mutations in several gp120 envelope glycoprotein contexts. The gp120 glycoproteins with the T257S-plus-S375W double mutation (T257S+S375W) have a superior antigenic profile compared to the originally identified single S375W replacement in terms of enhanced recognition by the broadly neutralizing CD4 binding-site antibody b12. Isothermal titration calorimetry measuring the entropy of the gp120 interaction with CD4 indicated that the double mutant was also stabilized into the CD4-bound state, with increasing relative fixation between core, full-length monomelic, and full-length trimeric versions of gp120. A significant increase in gp120 affinity for CD4 was also observed for the cavity-filling mutants relative to wild-type gp120. The most conformationally constrained T257S+S375W trimeric gp120 proteins were selected for immunogenicity analysis in rabbits and displayed a trend of improvement relative to their wild-type counterparts in terms of eliciting neutralizing antibodies. Together, the results suggest that conformational stabilization may improve the ability of gp120 to elicit neutralizing antibodies.",
author = "Barna Dey and Marie Pancera and Krisha Svehla and Yuuei Shu and Xiang, {Shi Hua} and Jeffrey Vainshtein and Yuxing Li and Joseph Sodroski and Kwong, {Peter D.} and Mascola, {John R.} and Richard Wyatt",
year = "2007",
month = "6",
day = "1",
doi = "10.1128/JVI.02500-06",
language = "English (US)",
volume = "81",
pages = "5579--5593",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state

T2 - Antigenicity, biophysics, and immunogenicity

AU - Dey, Barna

AU - Pancera, Marie

AU - Svehla, Krisha

AU - Shu, Yuuei

AU - Xiang, Shi Hua

AU - Vainshtein, Jeffrey

AU - Li, Yuxing

AU - Sodroski, Joseph

AU - Kwong, Peter D.

AU - Mascola, John R.

AU - Wyatt, Richard

PY - 2007/6/1

Y1 - 2007/6/1

N2 - The human immunodeficiency virus type 1 exterior gp120 envelope glycoprotein is highly flexible, and this flexibility may contribute to the inability of monomelic gp 120 immunogens to elicit broadly neutralizing antibodies. We previously showed that an S375W modification of a critical interfacial cavity central to the primary receptor binding site, the Phe43 cavity, stabilizes gp120 into the CD4-bound state. However, the immunological effects of this cavity-altering replacement were never tested. Subsequently, we screened other mutations that, along with the S375W alteration, might further stabilize the CD4-bound state. Here, we define a selected second cavity-altering replacement, T257S, and analyze the double mutations in several gp120 envelope glycoprotein contexts. The gp120 glycoproteins with the T257S-plus-S375W double mutation (T257S+S375W) have a superior antigenic profile compared to the originally identified single S375W replacement in terms of enhanced recognition by the broadly neutralizing CD4 binding-site antibody b12. Isothermal titration calorimetry measuring the entropy of the gp120 interaction with CD4 indicated that the double mutant was also stabilized into the CD4-bound state, with increasing relative fixation between core, full-length monomelic, and full-length trimeric versions of gp120. A significant increase in gp120 affinity for CD4 was also observed for the cavity-filling mutants relative to wild-type gp120. The most conformationally constrained T257S+S375W trimeric gp120 proteins were selected for immunogenicity analysis in rabbits and displayed a trend of improvement relative to their wild-type counterparts in terms of eliciting neutralizing antibodies. Together, the results suggest that conformational stabilization may improve the ability of gp120 to elicit neutralizing antibodies.

AB - The human immunodeficiency virus type 1 exterior gp120 envelope glycoprotein is highly flexible, and this flexibility may contribute to the inability of monomelic gp 120 immunogens to elicit broadly neutralizing antibodies. We previously showed that an S375W modification of a critical interfacial cavity central to the primary receptor binding site, the Phe43 cavity, stabilizes gp120 into the CD4-bound state. However, the immunological effects of this cavity-altering replacement were never tested. Subsequently, we screened other mutations that, along with the S375W alteration, might further stabilize the CD4-bound state. Here, we define a selected second cavity-altering replacement, T257S, and analyze the double mutations in several gp120 envelope glycoprotein contexts. The gp120 glycoproteins with the T257S-plus-S375W double mutation (T257S+S375W) have a superior antigenic profile compared to the originally identified single S375W replacement in terms of enhanced recognition by the broadly neutralizing CD4 binding-site antibody b12. Isothermal titration calorimetry measuring the entropy of the gp120 interaction with CD4 indicated that the double mutant was also stabilized into the CD4-bound state, with increasing relative fixation between core, full-length monomelic, and full-length trimeric versions of gp120. A significant increase in gp120 affinity for CD4 was also observed for the cavity-filling mutants relative to wild-type gp120. The most conformationally constrained T257S+S375W trimeric gp120 proteins were selected for immunogenicity analysis in rabbits and displayed a trend of improvement relative to their wild-type counterparts in terms of eliciting neutralizing antibodies. Together, the results suggest that conformational stabilization may improve the ability of gp120 to elicit neutralizing antibodies.

UR - http://www.scopus.com/inward/record.url?scp=34249827906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249827906&partnerID=8YFLogxK

U2 - 10.1128/JVI.02500-06

DO - 10.1128/JVI.02500-06

M3 - Article

C2 - 17360741

AN - SCOPUS:34249827906

VL - 81

SP - 5579

EP - 5593

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 11

ER -